Dexmedetomidine vs. Midazolam Sedation for Endobronchial Ultrasound

• Status: Completed
• Trial end date: 2017-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The randomized controlled trial will compare efficacy and safety of dexmedetomidine to midazolam for sedation during endobronchial ultrasound

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Postgraduate Institute of Medical Education and Research
• Treatments: Dexmedetomidine; Fentanyl; Midazolam

Criteria

Inclusion Criteria:

• Age 18 years or more

• American Society of Anesthesiologists physical status I or II

• Presence of hilar and/or mediastinal lymph nodes on thoracic CT scan

Exclusion Criteria:

• Known allergy to dexmedetomidine or midazolam or fentanyl

• Documented coagulopathy

• Pregnancy

• Hemodynamic instability (hypotension, arrhythmia, recent acute coronary event)

• Neuropsychiatric illness

• History of previous endobronchial ultrasound procedure

• Refusal to provide consent